Bismuth Intoxication
Bismuth, also called Wissmuth, is widely used in medications and cosmetics. Toxic doses can lead to cardiac arrhythmia, liver damage, kidney dysfunction, and more. Chelation therapy promises to be an alternative treatment...[more]
19.05.2018
Glyphosate herbicides contain toxic heavy metals, including arsenic
Glyphosate-based herbicides contain toxic heavy metals such as arsenic, lead, chromium and nickel, a new study has found. These are not declared and are normally banned due to their toxicity. They are also known to be endocrine...[more]
12.05.2018
Dubious Bioresonance
In Germany, pharmacies, non-medical practitioners, nutritionists and health food stores advertise for a novel Bioresonance Test. This noninvasive test provides over 200 health parameters. Experts have examined the equipment....[more]
02.05.2018
ZAEN Medical Congress Freudenstadt
We are represented today Saturday, April 21, 2018 and tomorrow Sunday, April 22, 2018 at the 134th ZAEN Congress in Freudenstadt. Please visit us at our exhibition stand 39a. In addition, you can admire our new exhibition...[more]
21.04.2018
2nd round table for mercury-free dentistry in Berlin on April 23, 2018
On July 1, 2018, so in less than three months, amalgam fillings for children, pregnant women and breastfeeding women will be banned under the new mercury directive of the European Union in the whole European Union. In Germany,...[more]
15.04.2018
Hallmarks of Alzheimer disease are evolving relentlessly in Metropolitan Mexico City infants, children and young adults. APOE4 carriers have higher suicide risk and higher odds of reaching NFT stage V at <=40 years of age
Exposures to fine particulate matter (PM2.5) and ozone (O3) above USEPA standards are associated with Alzheimer's disease (AD) risk. Metropolitan Mexico City (MMC) residents have life time exposures to PM2.5 and O3 above USEPA...[more]
15.04.2018
Contrast agents containing gadolinium: Deposits in the brain and other tissues
The Federal Institute for Drugs and Medical Devices (BfArM) issues information on the realisation of the EU Commission's implementing decision following the European Medicines Agency's (EMA) scientific review of contrast agents...[more]
30.03.2018